NCT03504930 COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity. Status UNKNOWN Phase N/A
NCT03483246 Impact of Fecal Microbiota Transplantation in Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03482648 First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03478956 A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE1
NCT03455751 Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery Status TERMINATED Phase NA
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients Status COMPLETED Phase N/A
NCT03441893 Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03415711 PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis Status TERMINATED Phase NA
NCT03404557 Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC Status COMPLETED Phase N/A
NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03394586 Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab Status UNKNOWN Phase N/A
NCT03378921 Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis Status COMPLETED Phase PHASE2
NCT03368118 Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03359642 Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy Status COMPLETED Phase NA
NCT03358706 A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis Status TERMINATED Phase PHASE1
NCT03327558 Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1